SRK, Ajay Devgn & Tiger Shroff Legal Trouble Over Vimal Ad

The Food and Drug Administration (FDA) has officially issued a show cause notice to Bollywood superstars Shah Rukh Khan, Ajay Devgn, and Tiger Shroff over their endorsement of Vimal Elaichi, a popular pan masala brand. The regulatory action arrives after the agency flagged concerns regarding the promotion of a tobacco-adjacent product by high-profile public figures, a practice that has long been under scrutiny in India. The notice demands an explanation from the actors regarding their participation in the advertising campaign, with the potential for further legal proceedings if their responses are deemed insufficient.

The development marks a significant escalation in the ongoing debate over celebrity endorsements of products that, while legally sold, are often associated with health risks. Vimal Elaichi, though technically a non-tobacco pan masala, has frequently been at the center of criticism due to its branding and marketing strategies. The FDA’s action suggests that the agency is now taking a harder stance on influential personalities who lend their faces to such brands, particularly given the massive reach and impact their endorsements have on younger audiences. For Shah Rukh Khan, who is widely recognized globally for his iconic role in the 1995 classic Dilwale Dulhania Le Jayenge, this legal notice introduces an unwelcome regulatory complication to his otherwise celebrated career.

The show cause notice requires the three actors to respond within a specified timeframe, outlining the grounds on which they believe the advertisements should not be penalized or withdrawn. According to sources familiar with the matter, the FDA has cited specific provisions that govern misleading advertising and the promotion of products that may be harmful to public health. While the actors have not yet issued an official statement, industry insiders suggest that their legal teams are already preparing detailed replies. The core of their defense may hinge on the fact that Vimal Elaichi is not classified as a tobacco product, as it contains no nicotine or tobacco leaves, which could complicate any attempt to ban the advertisement outright.

Regulatory Scrutiny Intensifies

This is not the first time the FDA has taken aim at pan masala endorsements, but the involvement of three A-list actors simultaneously raises the stakes considerably. In recent years, the regulatory body has cracked down on misleading health claims and unsubstantiated benefits in various consumer goods, yet celebrity-driven campaigns for such products have largely continued unabated. The issuance of this notice signals a possible shift in enforcement priorities, with authorities seemingly more willing to hold individuals accountable rather than just the manufacturing companies. Legal experts note that under current Indian law, celebrities can be held liable for endorsements that are found to be deceptive or contrary to public interest, even if the product itself is legal.

For Ajay Devgn, who has a massive fan following across the Hindi-speaking belt, and Tiger Shroff, known for his action-hero persona and youthful appeal, the notice arrives at a delicate time. Both stars have carefully cultivated images centered on fitness and discipline, making their association with a pan masala brand somewhat paradoxical in the public eye. Critics have pointed out this contradiction, arguing that their endorsement undermines the very health-conscious personas they project on screen and in sponsored content. The FDA’s intervention may force all three actors to reconsider not just their legal standing but also their public messaging strategy moving forward.

Implications for the Advertising Industry

The broader advertising industry is watching this case closely, as its outcome could set a precedent for how endorsements are regulated in India. If the FDA succeeds in imposing penalties or demanding the withdrawal of the advertisement, it could have a chilling effect on similar campaigns featuring celebrities for controversial products. Conversely, if the actors successfully defend their participation, it may embolden other stars to continue accepting lucrative endorsement deals without fear of regulatory backlash. The financial stakes are considerable, as celebrity endorsement fees for such brands often run into crores, making them a significant revenue stream for both the talent and the marketing agencies that broker these deals.

Currently, Vimal Elaichi has not removed any of the advertisements featuring the three actors from television or digital platforms. It remains to be seen whether the company will voluntarily pull the campaign while the matter is being resolved or wait for the FDA’s next course of action. The agency has the authority to issue fines, mandate public apologies, or even initiate criminal proceedings under certain consumer protection laws, although such outcomes are rare in the initial stages of a show cause notice.

Awaiting Responses

As of August 16, 2026, none of the three actors have publicly commented on the notice, leaving fans and media alike speculating on their next steps. Shah Rukh Khan, who has previously navigated legal challenges and controversies with a mix of silence and eventual court statements, is expected to handle the matter through his established legal channels. Ajay Devgn, known for his reserved public demeanor, may address the issue only if it escalates further. Tiger Shroff, who has a more active social media presence, has remained conspicuously quiet since the news broke, though his team is believed to be coordinating with the other parties involved.

The coming weeks will be crucial in determining whether this remains a procedural formality or evolves into a full-blown legal battle. For now, the entertainment industry is abuzz with speculation, and the FDA’s decision to target such prominent figures has undoubtedly sent a strong message: celebrity status no longer shields individuals from accountability when it comes to public health concerns. The ball is now in the court of Khan, Devgn, and Shroff, and their responses will likely shape the future of celebrity endorsements in India’s consumer market.

Source: Filmibeat